EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Minor Haplotype Variant Determines the Pathogenicity of the p.Ile279Thr Substitution in the Primary Hyperoxaluria Type 1 Gene, AGXT

Luana Ruta, Andrea G Cogal, Gioena Pampalone, David J Sas, John C Lieske, Gill Rumsby, Barbara Cellini iD, Peter C Harris

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Luana Ruta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Hyperoxaluria, Primary, Transaminases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Ministero dell'Istruzione, dell'Università e della Ricerca, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human alanine:glyoxylate aminotransferase (AGT) is a liver peroxisomal enzyme that metabolizes glyoxylate, the oxalate precursor, to glycine. AGT deficiency, due to recessive pathogenic changes in the AGXT gene, results in calcium oxalate accumulation and kidney stones, a condition known as primary hyperoxaluria type 1 (PH1). Most missense variants lead to PH1 by causing AGT misfolding, but their effects manifest differently based on the presence of two polymorphic variants, p.Pro11Leu (p.P11L) and p.Ile340Met (p.I340M), which are usually present in linkage disequilibrium and generate the minor haplotype. While the p.P11L substitution reduces AGT global stability and worsens the effects of pathogenic changes, the p.I340M exerts a stabilizing effect whose role on PH1 pathogenesis has never been elucidated. The p.Ile279Thr (p.I279T) variant is frequent in healthy populations (0.29%), mainly on the major allele, but we present data from six PH1 families (eight patients) suggesting p.I279T as a PH1 pathogenic allele. Interestingly, in these families, p.Thr279 is always associated with p.Leu11 and p.Ile340, thus with a split AGXT haplotype. Analysis of the effects of the p.I279T mutation by in silico predictions, biochemical analyses on purified proteins, and expression in two cellular models of disease ( AGXT1 ‐KO HepG2 and CHO cells) shows that it causes a folding defect that is exacerbated by p.P11L but mitigated by p.I340M, thus explaining why p.Thr279 is pathogenic just on the p.Leu11–p.Ile340 haplotype. These data indicate that genetic screenings for PH1 should document the AGXT haplotype, including its components, to obtain an accurate diagnosis and possible prognostic information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperoxaluria, PrimaryTransaminasesHumansHaplotypesMaleAnimalsFemalePedigreeMutation, MissenseCHO CellsChildCricetulusAmino Acid Substitution

Stichwörter der Autor:innen

primary hyperoxaluria: polymorphismpyridoxal phosphate: pathogenic varianrare disease

Substanzen

Alanine-glyoxylate transaminaseTransaminases

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • University College London Hospitals, London, UK.
  • Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Barbara Cellini

Förderung

  • NIDDK NIH HHS
  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Ruta, L., Cogal, A. G., Pampalone, G., Sas, D. J., Lieske, J. C., Rumsby, G., Cellini, B., & Harris, P. C. (2025). A Minor Haplotype Variant Determines the Pathogenicity of the p.Ile279Thr Substitution in the Primary Hyperoxaluria Type 1 Gene, AGXT. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70052

Vancouver

Ruta L, Cogal AG, Pampalone G, Sas DJ, Lieske JC, Rumsby G, et al. A Minor Haplotype Variant Determines the Pathogenicity of the p.Ile279Thr Substitution in the Primary Hyperoxaluria Type 1 Gene, AGXT. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70052

BibTeX
@article{Ruta2025,
  author = {Ruta, Luana and Cogal, Andrea G and Pampalone, Gioena and Sas, David J and Lieske, John C and Rumsby, Gill and Cellini, Barbara and Harris, Peter C},
  title = {A Minor Haplotype Variant Determines the Pathogenicity of the p.Ile279Thr Substitution in the Primary Hyperoxaluria Type 1 Gene, AGXT},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70052}
}
Kostenlos starten →